Our present investigations evidence a correspondence among MCAM/MUC18 mRNA blood level, detection and degree of expression of this marker on the corresponding primary melanoma tissue, tumour thickness, AJCC stages and clinical outcome. The gene discussed is MCAM; the disease is melanoma.